ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

9 links0 made here, not in the record13 judgments1 judge (the rules as one: Rule based)0 record changes seen
Rule based
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07677813Orelabrutinib Combined WithInduction Therapy Followedby Sequential MonotherapyMaintenance in MCD SubtypeDiffuse Large B-cellLymphomaOu Bai, MD/PHDPhase 2 · not yet recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSDendritic Cell Sarcoma, Int…The registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSINT014072Entry “R-CHOP+Orelabrutinib”, read by…›As of now · Rule based · TestedTestedOrelabrutinibEntry “R-CHOP+Orelabrutinib”, read by…›As of now · Rule based · TestedAs of now · Rule based · TestedAs of now · Rule based · TestedTestedINT012047Entry “POLA-R-CHP+orelabrutinib”, rea…›As of now · Rule based · TestedTestedINT012046Entry “R-miniCHOP +orelabrutinib”, re…›As of now · Rule based · TestedTestedZuberitamabEntry “Zuberitamab-CHOP+orelabrutinib…›As of now · Rule based · TestedAs of now · Rule based · TestedAs of now · Rule based · TestedTestedCyclophosphamideEntry “POLA-Hi-CHP+orelabrutinib”, re…›As of now · Rule based · TestedTestedRituximabEntry “RMTO”, read by our name rule›As of now · Rule based · TestedTestedPolatuzumab vedotinEntry “Pola-R-miniCHP+O”, read by our…›As of now · Rule based · BackgroundAs of now · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Dendritic Cell Sarcoma, Interdigitating

From the registry record0 judgments on this link
RegistryDendritic Cell Sarcoma, Interdigitating, as filedthe registry files the study under it
=as filed
No judgmentUnchangedshown as the registry files it

All judgments on this study

WhenLinkJudgeDecisionState
As of nowINT014072Rule based · role ruleTestedCurrent
As of nowOrelabrutinibRule based · role ruleTestedCurrent
As of nowOrelabrutinibRule based · role ruleTestedCurrent
As of nowOrelabrutinibRule based · role ruleTestedCurrent
As of nowINT012047Rule based · role ruleTestedCurrent
As of nowINT012046Rule based · role ruleTestedCurrent
As of nowZuberitamabRule based · role ruleTestedCurrent
As of nowZuberitamabRule based · role ruleTestedCurrent
As of nowZuberitamabRule based · role ruleTestedCurrent
As of nowCyclophosphamideRule based · role ruleTestedCurrent
As of nowRituximabRule based · role ruleTestedCurrent
As of nowPolatuzumab vedotinRule based · role ruleBackgroundCurrent
As of nowPolatuzumab vedotinRule based · role ruleTestedCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.